OP 5.3 - 00082 1-year treatment with ponatinib provides protection of CD4+T cells against HIV that is maintained at least 1 year more after treatment interruption - M. Manzanares; F. Ramos-Martín; G. Casado-Fernández; M. Torres; E. Mateos; L. Vigón; S. Rodríguez-Mora; V. García-Gutiérrez; V. Planelles; M. Coiras (Elsevier, 2022)